XML 113 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity - Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Basic      
Net income attributable to common stockholders $ 330,065 $ 284,829 $ 317,412
Net income attributable to common stockholders and noncontrolling interest $ 330,065 $ 284,829 $ 317,412
Weighted average shares outstanding (in shares) 184,641,642 165,355,167 137,830,691
Weighted average shares outstanding (in shares) 184,641,642 165,355,167 137,830,691
Net income per common share (in dollars per share) $ 1.79 $ 1.72 $ 2.30
Diluted      
Net income attributable to common stockholders $ 330,065 $ 284,829 $ 317,412
Net income attributable to noncontrolling interest 29,122 28,044 38,507
Interest expense on convertible notes 24,832 20,166  
Net income attributable to common stockholders and noncontrolling interest $ 384,019 $ 333,039 $ 355,919
Weighted average shares outstanding (in shares) 184,641,642 165,355,167 137,830,691
Dilutive effect of OP Units (in shares) 16,293,589 16,304,638 16,818,722
Dilutive effect of restricted stock units (in shares) 17,294,392 16,900,204 933,233
Dilutive effect of convertible notes (in shares) 613,990 552,621 506,949
Weighted average shares outstanding (in shares) 218,843,613 199,112,630 156,089,595
Diluted earnings per common share (in dollars per share) $ 1.75 $ 1.67 $ 2.28
Mr. Ivan Kaufman | Performance-Based Restricted Stock      
Diluted      
Vesting period (in years) 4 years